This report from Life Science Intelligence provides the latest market data for the Global ENT Endoscopic Surgery Devices Market. Information covered by this report includes:
The global market for Ear, Nose, and Throat (ENT) endoscopic surgery devices was valued at an estimated $1.6 billion in 2020 and is projected to increase at a CAGR (2020-2024) of 10.2%. Product segments covered by this report include ENT endoscopic surgical instruments, balloon sinus dilatation catheters, ENT rigid endoscopes, and bronchoscopes.
This report covers the impact of COVID-19 on the ENT endoscopic surgery devices market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as Karl Storz, Olympus, Intuitive Surgical, and others. The report provides insights into trends, drivers, and limiters of the ENT endoscopic surgery devices market, as well as highlights potential opportunities.
The ENT endoscopic surgery devices market was negatively impacted by the COVID-19 pandemic. The pandemic has affected elective surgical procedures markedly, as many non-critical procedures have been cancelled or postponed so that healthcare resources have been conserved for the treatment of COVID-19 and other critically ill patients.
Olympus and Karl Storz together dominate the ENT endoscopic surgery devices market and hold an estimated 80% of the global market share. Other companies with notable market share include Entellus, Acclarent, Conmed, and Intuitive Surgical.
Endoscopic ENT procedures include procedures to treat conditions such as Eustachian Tube Dysfunction (ETD), sinusitis, nasal airway obstruction (NAO), sleep disorder, corrective breathing, middle ear fluid drain, nasal septal reconstruction, adenoidectomy, tonsillectomy, and tumor removal.